Biomarker test could cut unnecessary antifungal use in ICU
NCT ID NCT02154178
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether using special fungal markers (biomarkers) could help doctors safely stop antifungal drugs earlier in ICU patients. The goal was to reduce the length of treatment and avoid unnecessary side effects. The study included 110 critically ill adults who needed antifungal therapy for the first time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ICU, Salengro Hospital, University Hospital of Lille
Lille, Nord, 59035, France